Tetrabenazine
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1848 publications
Decoding instrumental lever pressing from prefrontal, accumbens, and hippocampal local field potentials: conservation across sex, task, and dopamine depletion.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2026
Isolated Hemichorea-Hemiballismus as the Presenting Manifestation of Thalamic Intracerebral Hemorrhage: A Long-Term Treatment Course With Tetrabenazine and Aripiprazole.
Journal: Cureus
Published: September 04, 2026
Real-world treatment patterns and outcomes of deutetrabenazine in patients with chorea associated with Huntington disease: A retrospective chart review study.
Journal: Journal of Huntington's disease
Published: August 14, 2026
Valbenazine improves quality of life, functionality, and movement severity in patients with tardive dyskinesia: findings from the KINECT-PRO™ study.
Journal: CNS spectrums
Published: August 10, 2026
Vesicular Monoamine Transporters at the Crossroads of Structure and Function: Advances, Challenges, and Future Perspectives.
Journal: Annual review of pharmacology and toxicology
Published: August 07, 2026
Perceptions on the diagnosis and treatment of patients with tardive dyskinesia: a cross-sectional survey among physicians in Italy.
Journal: Rivista di psichiatria
Published: July 21, 2026
Effect of Deuterated Drugs on Safety: Insights from Pharmacovigilance Data Analysis.
Journal: Biological & pharmaceutical bulletin
Published: June 21, 2026
Efficacy and Safety of Deutetrabenazine in Tourette Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal: Psychopharmacology bulletin
Published: June 10, 2026
Management of severe tardive dyskinesia induced by arpiprazole in a schizophrenic patient: a case report.
Journal: Journal of medical case reports
Published: May 31, 2026
Acute Onset Extrapyramidal Symptoms With Clozapine: A Report of a Rare Case.
Journal: Cureus
Published: May 11, 2026
Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia.
Journal: Psychiatry and clinical neurosciences
Published: May 09, 2026
Last Updated: 11/08/2026